Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
Clinical trial NCT04215809 · RECRUITING
Trial details
- NCT number
- NCT04215809
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-02
- Primary completion
- 2025-10-31
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.